Jeffrey Hrkach

Jeffrey Hrkach

Directeur Technique/Scientifique/R&D chez
Nvelop Therapeutics, Inc.
60 ans
Health Technology
Consumer Services
Finance

Profil

Jeffrey Hrkach is currently an Advisor at Atlas Venture Advisors, Inc. and the Chief Technology Officer at Nvelop Therapeutics, Inc. He previously worked as the Director-Pulmonary Formulations at Alkermes, Inc., Senior Director-Drug Delivery at Momenta Pharmaceuticals, Inc., Manager at Sandoz, Inc., Principal at Novartis AG, and Senior Vice President-Technology Development at Frequency Therapeutics, Inc. He also served as the Chief Technology Officer at DNIB Unwind, Inc. from 2007 to 2014.
Dr. Hrkach holds a doctorate degree from Carnegie Mellon University and an undergraduate degree from Philadelphia College of Pharmacy.

Postes actifs de Jeffrey Hrkach

SociétésPosteDébut
Consultant / Advisor 01/03/2022
Directeur Technique/Scientifique/R&D 01/03/2022

Anciens postes connus de Jeffrey Hrkach

SociétésPosteFin
DNIB UNWIND INC Directeur Technique/Scientifique/R&D 01/12/2014
KORRO BIO, INC. Directeur Technique/Scientifique/R&D -
Corporate Officer/Principal -
NOVARTIS AG Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jeffrey Hrkach

Formation de Jeffrey Hrkach

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Jeffrey Hrkach